“Shinpoong Pharmaceutical’s Piramax, Phase 3 clinical trial for Corona 19 in Africa”
[헤럴드경제=손인규 기자]Shinpoong Pharm’s antimalarial treatment’Piramax (ingredient names pyronaridin altesunate) is expected to undergo a phase 3 clinical trial in Africa to see the effect of the treatment of a novel coronavirus infection (Corona 19). According to industry sources on the 6th, the UK Liverpool University Research Institute recently registered a phase 3 clinical trial on … Read more
